CClinicalTrials.gg
Not yet recruitingNCT06730048preeclamsideUpdated Dec 12, 2024

The Effect of Augmented Reality Based Training on Preeclampsia Case

An interventional study of Experimental Group and Control group (placebo) in Preeclampsia, Nursing Care and Pregnancy, sponsored by Inonu University. Not yet recruiting at 1 site in Turkey. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-12.

Sponsored by Inonu University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 7 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

However, no study has been found in the care of preeclampsia, which is highly effective on maternal and fetal health. Therefore, this study was planned to determine the effect of augmented reality-based training on the diagnosis and intervention planning skills of nursing students.

Read the detailed description

Although pregnancy is a physiological process in women's lives, many women lose their lives due to the lack of timely and appropriate treatment of the complications it brings with it. According to the World Health Organization 2024 report, approximately 800 women die every day due to preventable causes related to pregnancy and childbirth. Preeclampsia, which is among the hypertensive diseases of pregnancy, is a complication of pregnancy and ranks among the top three causes of maternal mortality worldwide. Preeclampsia is defined as hypertension that develops after the 20th week of pregnancy and is accompanied by proteinuria/thrombocytopenia, renal failure, liver dysfunction, and cerebral/visual symptoms.

Considering the risks of preeclampsia complications, taking precautions before the onset of complications and treating complications with appropriate methods are extremely important in reducing the mortality rates of both pregnant and fetus. In order to maintain safe patient care and the health of individuals, nurses should know what kind of nursing care should be applied in the antenatal period to diagnose, evaluate and prevent complications of preeclampsia. In the literature, it is recommended that nursing care for preeclampsia patients should include the diagnoses of infection risk, disruption in sleep pattern, acute pain, constipation, impaired physical movement, lack of self-care, and fatigue. Nursing care should include individualized, holistic, systematic, high quality, feasible, applicable, sustainable care methods including technological methods, models and theories for all pregnant women with more than 2 of the risks of preeclampsia by ACOG.

Technological methods, which have been frequently used in the health system in recent years, are used because they are cheap, usable, accelerate the decision-making process, and reduce workload. Virtual reality (VR) applications are technological applications that create a reality environment with the help of scenarios and facilitate learning complex cases and diseases by increasing students' knowledge and skills. In addition, this method allows students to develop critical thinking skills, participate in clinical decision-making processes and receive feedback. In the literature, VR application has been used in triage patients and nursing care of pediatric patients. However, no study has been found in the care of preeclampsia, which is highly effective on maternal and fetal health. Therefore, this study was planned to determine the effect of augmented reality-based training on the diagnosis and intervention planning skills of nursing students.

02

Conditions studied

  • Preeclampsia
  • Nursing Care
  • Pregnancy
  • Augmented Reality

Browse trials for

Keywords

  • preeclampsia
  • nursing care
  • pregnancy
  • augmented reality
03

In context

Pre-Eclampsia

882 studies on the registry are indexed under Pre-Eclampsia; 237 are open to participants now.

This study's planned enrollment of 84 is below the median of 110 across 468 interventional studies indexed under Pre-Eclampsia.

Browse Pre-Eclampsia studies →

Lead sponsor

Inonu University is the lead sponsor of 375 studies on the registry; 86 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Continuing the course of Women's Health and Diseases Nursing,

    • Volunteering to participate in the research,
    • No physical or psychological health problems preventing the completion of the research forms.

Exclusion criteria

Exclusion Criteria:

    • Not watching the whole case given with virtual glasses,
  • Failure to attend class during the week of the preeclampsia lecture in the course syllabus.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
84 participants (estimated)

Study arms

  • Experimental
    experimental group

    An appointment will be made to meet with the students in the experimental group in a suitable classroom of the school. After the pre-test data, the students in the experimental group will be shown the preeclampsia case with virtual glasses for about 5-10 minutes. Then the post-test will be applied. A scenario including preeclampsia case and nursing care practices will be created in the virtual reality environment, and 10 experts will be consulted about the scenario before the students are shown it. This application will not have any side effects.

    Other: Experimental Group

  • Other
    control group

    After the pre-test data, the preeclampsia case will be explained to the students in the control group with the classical lecture method in the Women's Health and Diseases Nursing course and the post-test will be applied.

    Other: Control group (placebo)

Interventions

  • OtherExperimental Group

    An appointment will be made to meet with the students in the experimental group in a suitable classroom of the school. After the pre-test data, the students in the experimental group will be shown the preeclampsia case with virtual glasses for about 5-10 minutes. Then the post-test will be applied. A scenario including preeclampsia case and nursing care practices will be created in the virtual reality environment, and 10 experts will be consulted about the scenario before the students are shown it. This application will not have any side effects.

  • OtherControl group (placebo)

    After the pre-test data, the preeclampsia case will be explained to the students in the control group with the classical lecture method in the Women's Health and Diseases Nursing course and the post-test will be applied.

06

What researchers measure

Primary outcomes

  1. Preeclampsia Nursing Care Plan

    he nursing care plan consists of 4 open-ended questions including nursing diagnosis, risks, interventions and evaluation. Students will receive 3 points for each correct diagnosis. If they write all of the diagnoses, they will receive a total of 48 points from the diagnoses. If they correctly write 2 of the risk factors related to the diagnosis of preeclampsia added to the diagnoses for each diagnosis, they will receive 1 point from each diagnosis. They will receive a maximum of 16 points from risks. If they write at least 5 nursing interventions for each diagnosis, they will receive 2 points for each diagnosis. A maximum of 32 points will be obtained from interventions. The evaluation part will be 0.25 points. If they write the evaluations of all diagnoses correctly, they will receive 4 points. A total of 100 points can be obtained from the nursing care plan, with a minimum of 0 and a maximum of 48+16+32+32+4.

    Time frame: one month

Secondary outcomes

  1. Participant Information Form

    The information form, which was created by utilizing the literature, consists of a total of 10 questions (student's name, surname, telephone number, student number, age, gender, pre-preparation information, etc.).

    Time frame: one month

  2. Preeclampsia Knowledge Test

    The preeclampsia information form (preeclampsia symptoms, ric factors, laboratory findings of preeclampsia, etc.) created by the researchers in line with the literature consists of a total of 10 questions. Each question is evaluated as 1 point and a minimum score of 0 and a maximum score of 10 can be obtained from the test. Before finalizing the information form, the opinions of 10 experts will be taken to determine its suitability.

    Time frame: one month

  3. Presence Scale

    The Turkish validity and reliability study of the scale developed by Witmer et al. (2005) was conducted by Gökoğlu and Çakıroğlu (2019). Consisting of 29 items, the five-point Likert-type scale has five sub-dimensions: Engagement, Adaptation/Environmentalization, Sensory Engagement, Interaction, and Interface Quality. High scores obtained from the scale indicate that presence is effective.

    Time frame: one month

07

Study locations

1 site
  • Inonu University
    Malatya, 44200, Turkey
    • simge öztürk, Ph.D · Contact · sozturk@bartin.edu.tr · 05398751788
    • sermin timur taşhan, Ph.D · Sub investigator
    • emine özbek, Rsc · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06730048
Lead sponsor
Inonu University
Responsible party
Simge Ozturk (Ph.D Student, Inonu University) — Principal investigator
First posted
Dec 12, 2024
Start date
Dec 20, 2024 (estimated)
Primary completion
Feb 20, 2025 (estimated)
Completion
Aug 20, 2025 (estimated)
Last update
Dec 12, 2024

Study contacts

simge öztürk, Ph.D
Contact
sozturk@bartin.edu.tr
05398751788

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion